...
首页> 外文期刊>Clinical Orthopaedics and Related Research >Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery.
【24h】

Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery.

机译:骨科大手术后低分子量肝素对门诊血栓预防的不依从性。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: According to some current guidelines, extended thromboprophylaxis after hip and knee arthroplasties is recommended. Outpatient prophylaxis with low molecular weight heparins (LMWH) is an important part of this prophylaxis, although the rates of adherence to these regimens is not known. QUESTIONS/PURPOSES: We determined (1) the degree of nonadherence (NA) of patients with LMWH outpatient prophylaxis, and (2) whether specific independent factors explain NA. METHODS: NA was determined by syringe count and by indirect and direct questions to patients. We defined six different NA indicators. To identify factors explaining LMWH NA, we used three different logistic regression models. RESULTS: NA rates ranged between 13% and 21% depending on the indicator used for measurement. Patients who were nonadherent missed between 38% and 53% of their outpatient LMWH injections. If patients attended an outpatient rehabilitation program, the probability for their NA increased substantially. Moreover, the NA probability increased with each additional day between acute hospitalization and start of rehabilitation (linking days). NA was lower for patients who feared thrombosis or who believed antithrombotic drugs to be the most important measure in thromboprophylaxis. LEVEL OF EVIDENCE: Level II, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.
机译:背景:根据目前的一些指南,建议在髋关节和膝关节置换术后扩大血栓预防。尽管对这些方案的依从率尚不清楚,但低分子量肝素(LMWH)的门诊预防是该预防的重要组成部分。问题/目的:我们确定(1)LMWH门诊患者预防的不依从程度(NA),以及(2)是否有特定的独立因素可以解释NA。方法:NA通过注射器计数以及对患者的直接和间接问题确定。我们定义了六个不同的NA指标。为了确定解释LMWH NA的因素,我们使用了三种不同的逻辑回归模型。结果:NA的比率介于13%和21%之间,具体取决于用于测量的指标。非依从性患者错过了其门诊LMWH注射的38%至53%。如果患者参加了门诊康复计划,其NA的可能性将大大增加。此外,从急性住院到开始康复之间的每一天(链接天数),NA的可能性都会增加。对于担心血栓形成或认为抗血栓形成药物是预防血栓形成的最重要措施的患者,NA较低。证据水平:II级,预后研究。有关证据水平的完整说明,请参见《作者指南》。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号